AI Assistant
Blog
Pricing
Log In
Sign Up
Typ-2-Diabetes – Aktuelle EASD-Daten: Patienten profitieren besonders von frühem Liraglutid-Einsatz
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
